Edition:
United States

Bioporto A/S (BIOPOR.CO)

BIOPOR.CO on Copenhagen Stock Exchange

3.29DKK
4:42am EDT
Change (% chg)

kr.-0.06 (-1.79%)
Prev Close
kr.3.35
Open
kr.3.36
Day's High
kr.3.36
Day's Low
kr.3.29
Volume
47,255
Avg. Vol
479,515
52-wk High
kr.3.84
52-wk Low
kr.1.40

Chart for

About

Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay... (more)
No analyst recommendations are available for .

Overall

Beta: 0.65
Market Cap(Mil.): kr.477.36
Shares Outstanding(Mil.): 142.49
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.51 16.21
EPS (TTM): -- -- --
ROI: -- 15.10 14.56
ROE: -- 16.34 13.83

BRIEF-Bioporto Q2 EBIT loss at DKK 8.4 million

* ‍EBIT FORECAST FOR FINANCIAL YEAR 2017 IS ADJUSTED FROM A LOSS BETWEEN DKK 26-29 MILLION TO A LOSS OF DKK 28 - 35 MILLION​

Aug 10 2017

BRIEF-Bioporto Q1 EBIT loss widens to DKK 9.3 million

* Q1 EBIT LOSS DKK 9.3 MILLION VERSUS LOSS DKK 5.4 MILLION YEAR AGO

May 04 2017

Earnings vs. Estimates

No consensus analysis data available.